Ace bio-IT team formed to spearhead phenome research
19 September, 2002 by Pete YoungA star-studded cast of researchers strongly seasoned with Australians has launched an ambitious bid to develop the next-generation bioinformatics needed to unravel the complexities of the phenome.
CAREER SPECIAL: The biotech gold rush
17 September, 2002 by Graeme O'NeillThe biotech gold rush is creating huge demand for people with many strings to their bow, as Graeme O'Neill discovers
CAREERS SPECIAL: Keeping the pace
17 September, 2002 by Graeme O'NeillAustralia's biotech industry is flourishing and the jobs are definitely out there, reports Graeme O'Neill
Benitec develops new knockout method for animal genes
16 September, 2002 by Melissa TrudingerQueensland company Benitec has developed a new method of knocking out genes in animals, combining its proprietary RNA interference (RNAi) technology with standard transgenic techniques.
The fine art of getting funding
09 September, 2002 by Pete YoungThe Centre of Bioinformatics and Biological Computing is a Western Australian research institute that has made thinking laterally about sources of funding into an art form.
GTG in third US licence deal
09 September, 2002 by Melissa TrudingerMelbourne-based Genetic Technologies has licensed its non-coding DNA patents to a third US genomics company, Perlegen Sciences, for about $1.6 million in cash and securities.
CSIRO research tool enables broad searches
02 September, 2002 by Melissa TrudingerA research tool from CSIRO has the ability to make it easier to get information on research activities in Australia's research institutions, universities and government departments.
Polymerat making a splash in the US
02 September, 2002 by Pete YoungAn Australian company that designs super-efficient surfaces for biochip and microplate assay systems used in high throughput proteomics screening has touched off an avalanche of US interest.
Singapore feature: money talks
02 September, 2002 by Iain ScottThe next time you start to worry about the drain of Australian scientific talent leaving town for better opportunities overseas, it might pay to remember the words of the director of Singapore's Institute for Molecular and Cell Biology, Chris Tan. Tan shrugs off such worries to opine that in Singapore's case, "Ideally, we'd be a 15-year revolving door."
Interview: Big picture stuff
02 September, 2002 by Iain ScottIt seems appropriate that the global CEO of a company engaged in the visualisation business is inclined to look at the big picture. Apart from being larger-than-life in person, Silicon Graphics (SGI) chief Bob Bishop is one of those outspoken, opinionated CEOs journalists love - one who is prepared to talk outside the finite square of profits and bottom lines to offer a world view.
Top WEHI researcher lured to UQ
30 August, 2002 by Pete YoungThe centre of gravity of Australian brain stem cell research has undergone a major shift with a change of residence by star researcher Prof Perry Bartlett and a large number of his team.
Gene database study backs 'privacy guardians'
29 August, 2002 by Pete YoungA new class of "privacy guardians" for genetic research databases and new laws requiring private sector researchers to conform to public sector ethical guidelines are two likely outcomes of a major Australian inquiry into the protection of genetic information.
Investment feature: can we manage?
27 August, 2002 by David BinningWhile many people are speculating as to whether Australia may become the next major hub for international biotech, questions are being asked of our local entrepreneurs and whether they have what it takes to turn IP into gold.
Bioinformatics a proving ground for IBM: Jasinski
26 August, 2002 by David BraueNew techniques for generating large amounts of biology-related data have given IT vendors new momentum in penetrating this traditionally low-tech segment of scientific research, a key IBM researcher told attendees at AusBiotech 2002 in Melbourne last week.
Bionomics and Hybrigen explain their partnership
26 August, 2002 by Melissa TrudingerOne of the more interesting collaborations between an Australian biotechnology company and a US company is the alliance between Adelaide genomics company Bionomics and proteomics company Hybrigen, based in Texas.
